Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Truist Securities Downgrades Maxar Technologies to Hold, Announces $53 Price Target

Truist Securities Downgrades Maxar Technologies to Hold, Announces $53 Price Target

Truist Securities analyst Michael Ciarmoli downgrades Maxar Technologies (NYSE:MAXR) from Buy to Hold and announces $53 price target.

byBenzinga Newsdesk

December 16, 2022

1 minute read

Truist Securities analyst Michael Ciarmoli downgrades Maxar Technologies (NYSE:MAXR) from Buy to Hold and announces $53 price target.

Analyst Ratings

RBC Capital Maintains Sector Perform Rating for Chemours: Here’s What You Need To Know

By Benzinga Insights

June 9, 1:00 PM

RBC Capital has decided to maintain its Sector Perform rating of Chemours (NYSE:CC) and raise its price target…

What’s Going On With Neurocrine Biosciences Stock Today?

By Vandana Singh

September 12, 2:33 PM

Neurocrine Biosciences Inc (NASDAQ: NBIX) announced positive topline data from the Phase 3 CAHtalyst Adult Study evaluating crinecerfont in adults with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase

NBIX

Analyst Ratings

Analyst Expectations for UDR’s Future

By Benzinga Insights

August 16, 12:00 PM

Over the past 3 months, 4 analysts have published their opinion on UDR (NYSE:UDR) stock. These analysts are…

UDR

News

Why Safe & Green Holdings Shares Are Down 25%

By Henry Khederian

May 6, 9:26 AM

Safe & Green Holdings shares are trading lower by 25% during Monday's session. The company announced pricing of a $4 million private placement priced at-the-market.

SGBX

Truist Securities Downgrades Maxar Technologies to Hold, Announces $53 Price Target

Related Posts

RBC Capital Maintains Sector Perform Rating for Chemours: Here’s What You Need To Know

What’s Going On With Neurocrine Biosciences Stock Today?

Analyst Expectations for UDR’s Future

Why Safe & Green Holdings Shares Are Down 25%